Arbutus Biopharma Corp. Q2 Earnings Summary
(RTTNews) - Below are the earnings highlights for Arbutus Biopharma Corp. (ABUS):
Earnings: $2.523 million in Q2 vs. -$19.796 million in the same period last year. EPS: $0.01 in Q2 vs. -$0.11 in the same period last year. Revenue: $10.739 million in Q2 vs. $1.726 million in the same period last year.
ABUS was up by 3.81% at $3.540 in the pre-market trade on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.